부산대학교 도서관

Bueno, C; Barrena, S; Bataller, A; Ortiz-Maldonado, V; Elliott, N; O'Byrne, S; Wang, G; Rovira, M; Gutierrez-Agüera, F; Trincado, JL; Gonzalez, M; Morgades, M; Sorigué, M; Barcena, P; Zanetti, SR; Torrebadell, M; Vega-García, N; Rives, S; Mallo, M; Sole, F; Mead, AJ; Roberts, I; Thongjuea, S; Psaila, B; Juan, M; Delgado, J; Urbano-Ispizua, Á; Ribera, J-M; Orfao, A; Roy, A; Menéndez, P

Blood
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
Experimental Hematology
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Petazzi P; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Roca-Ho H; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Castaño J; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Bueno C; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Spanish Network for Advanced Cell Therapies (TERAV), Carlos III Health Institute, Barcelona, Spain.; Spanish Cancer Network (CIBERONC), Carlos III Health Institute, Barcelona, Spain.; Alvarez N; Department of Cell Biology, Physiology, and Immunology, Faculty of Biology, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Forrester LM; Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Sevilla A; Department of Cell Biology, Physiology, and Immunology, Faculty of Biology, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Institute of Biomedicine, University of Barcelona (IBUB), Barcelona, Spain.; Fidanza A; Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Menendez P; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Spanish Network for Advanced Cell Therapies (TERAV), Carlos III Health Institute, Barcelona, Spain.; Spanish Cancer Network (CIBERONC), Carlos III Health Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, Casanova 143, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE

Juan Ramón Tejedor; Clara Bueno; Meritxell Vinyoles; Paolo Petazzi; Antonio Agraz-Doblas; Isabel Cobo; Raúl Torres-Ruiz; Gustavo F. Bayón; Raúl F. Pérez; Sara López-Tamargo; Francisco Gutierrez-Agüera; Pablo Santamarina-Ojeda; Manuel Ramírez-Orellana; Michela Bardini; Giovanni Cazzaniga; Paola Ballerini; Pauline Schneider; Ronald W. Stam; Ignacio Varela; Mario F. Fraga; Agustín F. Fernández; Pablo Menéndez

Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Journal of Clinical Investigation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname

Diaz de la Guardia, Rafael; Velasco-Hernandez, Talia; Gutierrez-Agüera, Francisco; Roca-Ho, Heleia; Molina, Oscar; Nombela-Arrieta, Cesar; Bataller, Alex; Fuster, Jose Luis; Anguita, Eduardo; Vives, Susana; Zamora, Lurdes; Nomdedeu, Josep F; Gomez-Casares, M Teresa; Ramírez-Orellana, Manuel; Lapillonne, Helene; Ramos-Mejia, Veronica; Rodríguez-Manzaneque, Juan Carlos; Bueno, Clara; Lopez-Millan, Belen; Menendez, Pablo

Velasco-Hernandez T; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Trincado JL; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Vinyoles M; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Closa A; The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.; EMBL Australia Partner Laboratory Network at the Australian National University Canberra Australian Capital Territory Australia.; Martínez-Moreno A; Josep Carreras Leukemia Research Institute Barcelona Spain.; Gutiérrez-Agüera F; Josep Carreras Leukemia Research Institute Barcelona Spain.; Molina O; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Rodríguez-Cortez VC; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Ximeno-Parpal P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Fernández-Fuentes N; Josep Carreras Leukemia Research Institute Barcelona Spain.; Petazzi P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Beneyto-Calabuig S; Centre for Genomic Regulation (CRG) The Barcelona Institute of Science and Technology Barcelona Spain.; Universitat Pompeu Fabra (UPF) Barcelona Spain.; Velten L; Centre for Genomic Regulation (CRG) The Barcelona Institute of Science and Technology Barcelona Spain.; Universitat Pompeu Fabra (UPF) Barcelona Spain.; Romecin P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Casquero R; Josep Carreras Leukemia Research Institute Barcelona Spain.; Abollo-Jiménez F; Bioinformatics Unit Maimonides Biomedical Research Institute of Córdoba (IMIBIC) Córdoba Spain.; de la Guardia RD; Josep Carreras Leukemia Research Institute Barcelona Spain.; GENYO, Center for Genomics and Oncological Research Pfizer/Universidad de Granada/Junta de Andalucía Granada Spain.; Lorden P; CNAG-CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Barcelona Spain.; Bataller A; Department of Hematology Hospital Clínic de Barcelona Barcelona Spain.; Lapillonne H; Centre de Recherce Saint-Antoine Armand-Trousseau Childrens Hospital Paris France.; Stam RW; Princess Maxima Center for Pediatric Oncology Utrecht The Netherlands.; Vives S; Josep Carreras Leukemia Research Institute Barcelona Spain.; Hematology Department ICO-Hospital Germans Trias i Pujol Barcelona Spain.; Torrebadell M; Hematology Laboratory Hospital Sant Joan de Déu Barcelona Spain.; Leukemia and Other Pediatric Hemopathies. Developmental Tumors Biology Group. Institut de Recerca Hospital Sant Joan de Déu Barcelona Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII Madrid Spain.; Fuster JL; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Sección de Oncohematología Pediátrica Hospital Clínico Universitario Virgen de la Arrixaca and Instituto Murciano de Investigación Biosanitaria (IMIB) Murcia Spain.; Bueno C; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; CIBER-ONC Barcelona Spain.; Sarry JE; Centre de Recherches en Cancérologie de Toulouse Université de Toulouse Inserm U1037, CNRS U5077 Toulouse France.; LabEx Toucan Toulouse France.; Équipe Labellisée Ligue Nationale Contre le Cancer Toulouse France.; Eyras E; The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.; EMBL Australia Partner Laboratory Network at the Australian National University Canberra Australian Capital Territory Australia.; Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain.; Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Barcelona Spain.; Menéndez P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; CIBER-ONC Barcelona Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain.; Department of Biomedicine, School of Medicine University of Barcelona Barcelona Spain.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Domínguez F; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (F.D., B.B., E.G.-L., P.G.-P.).; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; CIBER Cardiovascular Diseases (CIBERCV), Madrid, Spain (F.D., E.Z., E.G.-L., E.L.-P., P.G.-P.).; Lalaguna L; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Martínez-Martín I; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Piqueras-Flores J; Unidad de Cardiopatías Familiares. Servicio de Cardiología. Hospital Universitario de Ciudad Real, Spain (J.P.-F.).; Facultad de Medicina de Ciudad Real. Universidad de Castilla La Mancha, Spain (J.P.-F.).; Rasmussen TB; Department of Cardiology, Aarhus University Hospital, Denmark (T.B.R.).; Zorio E; CIBER Cardiovascular Diseases (CIBERCV), Madrid, Spain (F.D., E.Z., E.G.-L., E.L.-P., P.G.-P.).; Unidad de Cardiopatías Familiares, Muerte Súbita y Mecanismos de Enfermedad (CaFaMuSMe), Instituto de Investigación Sanitaria La Fe, Servicio de Cardiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain (E.Z.).; Giovinazzo G; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Prados B; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Ochoa JP; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Bornstein B; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (F.D., B.B., E.G.-L., P.G.-P.).; González-López E; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (F.D., B.B., E.G.-L., P.G.-P.).; CIBER Cardiovascular Diseases (CIBERCV), Madrid, Spain (F.D., E.Z., E.G.-L., E.L.-P., P.G.-P.).; Velázquez-Carreras D; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Pricolo MR; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Gutiérrez-Agüera F; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Bernal JA; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Herrero-Galán E; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Alegre-Cebollada J; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; Lara-Pezzi E; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; CIBER Cardiovascular Diseases (CIBERCV), Madrid, Spain (F.D., E.Z., E.G.-L., E.L.-P., P.G.-P.).; García-Pavía P; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (F.D., B.B., E.G.-L., P.G.-P.).; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (F.D., L.L., I.M.-M., G.G., B.P., J.P.O., D.V.-C., M.R.P., F.G.-A., J.A.B., E.H.-G., J.A.-C., E.L.-P., P.G.-P.).; CIBER Cardiovascular Diseases (CIBERCV), Madrid, Spain (F.D., E.Z., E.G.-L., E.L.-P., P.G.-P.).; Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, Spain (P.G.-P.).

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

Tejedor, Juan Ramón; Bueno, Clara; Vinyoles, Meritxell; Petazzi, Paolo; Agraz-Doblas, Antonio; Cobo, Isabel; Torres-Ruiz, Raúl; Bayón, Gustavo F.; Pérez, Raúl F.; López-Tamargo, Sara; Gutierrez-Agüera, Francisco; Santamarina-Ojeda, Pablo; Ramírez-Orellana, Manuel; Bardini, Michela; Cazzaniga, Giovanni; Ballerini, Paola; Schneider, Pauline; Stam, Ronald W.; Varela, Ignacio; Fraga, Mario F.; et al

Journal of Clinical Investigation (J CLIN INVEST), 7/1/2021; 131(13): 1-19. (19p)

Lopez-Millan B; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Diaz de la Guardia R; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Roca-Ho H; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Anguita E; Hematology Department, Hospital Clínico San Carlos, IdISSC, Universidad Complutense de Madrid, Madrid, Spain.; Islam ABMMK; Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh.; Romero-Moya D; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Prieto C; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Gutierrez-Agüera F; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Bejarano-Garcia JA; Hematology department, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Seville, Spain.; Hematology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.; Perez-Simon JA; Hematology department, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Seville, Spain.; Costales P; Entrechem SL, Oviedo, Spain.; Rovira M; Hematology Department, Hospital Clínico de Barcelona, Barcelona, Spain.; Marín P; Hematology Department, Hospital Clínico de Barcelona, Barcelona, Spain.; Menendez S; Pathology Service, Hospital del Mar, Barcelona, Spain.; Iglesias M; Pathology Service, Hospital del Mar, Barcelona, Spain.; Fuster JL; Oncohematology department, Sección de Oncohematología Pediátrica, Hospital Clínico Virgen de Arrixaca, Murcia, Spain.; Urbano-Ispizua A; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Hematology Department, Hospital Clínico de Barcelona, Barcelona, Spain.; ISCIII, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Anjos-Afonso F; Cardiff School of Biosciences, European Cancer Stem Cell Research Institute, Cardiff, UK.; Bueno C; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; Menendez P; Department of Biomedicine, Josep Carreras Leukemia Research Institute-Campus Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.; ISCIII, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

Lopez-Millan B; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Costales P; EntreChemSL, 33011 Oviedo, Spain.; Gutiérrez-Agüera F; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Díaz de la Guardia R; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.; Roca-Ho H; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Vinyoles M; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Rubio-Gayarre A; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.; Safi R; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Castaño J; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Romecín PA; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Ramírez-Orellana M; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación Sanitaria La Princesa, 28006 Madrid, Spain.; Anguita E; Servicio de Hematología, Hospital Clínico San Carlos, IdISSC, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.; Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, 85764 Munich, Germany.; Zamora L; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Hematology Department, ICO-Hospital Germans Trias i Pujol, 08916 Barcelona, Spain.; Rodríguez-Manzaneque JC; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.; Bueno C; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), 28029 Madrid, Spain.; Morís F; EntreChemSL, 33011 Oviedo, Spain.; Menendez P; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), 28029 Madrid, Spain.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Sánchez Martínez D; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain dsanchez@carrerasresearch.org bssantos@medicina.ulisboa.pt pmenendez@carrerasresearch.org.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029).; Tirado N; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029).; Mensurado S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Portugal.; Martínez-Moreno A; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029).; Romecín P; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029).; Gutiérrez Agüera F; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029).; Correia DV; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Portugal.; Silva-Santos B; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Portugal dsanchez@carrerasresearch.org bssantos@medicina.ulisboa.pt pmenendez@carrerasresearch.org.; Menéndez P; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain dsanchez@carrerasresearch.org bssantos@medicina.ulisboa.pt pmenendez@carrerasresearch.org.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029).; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.; Ramírez-Fernández Á; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Bueno C; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Argemí-Muntadas L; Immunotherapy and Cell Engineering Laboratory, Department of Engineering, Aarhus University, Aarhus, Denmark.; Fuentes P; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; Aguilar-Sopeña Ó; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Gutierrez-Agüera F; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Zanetti SR; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Tapia-Galisteo A; Molecular Immunology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain.; Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Segura-Tudela A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Castellà M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Marzal B; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Betriu S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Harwood SL; Immunotherapy and Cell Engineering Laboratory, Department of Engineering, Aarhus University, Aarhus, Denmark.; Compte M; Molecular Immunology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain.; Lykkemark S; Immunotherapy and Cell Engineering Laboratory, Department of Engineering, Aarhus University, Aarhus, Denmark.; Erce-Llamazares A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Rubio-Pérez L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Chair for Immunology UFV/Merck, Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, Madrid, Spain.; Jiménez-Reinoso A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Domínguez-Alonso C; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Neves M; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; Morales P; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Paz-Artal E; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Guedan S; Department of Hematology and Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain.; Sanz L; Molecular Immunology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain.; Toribio ML; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; Roda-Navarro P; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Juan M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Servei d'Immunologia, Hospital Clínic de Barcelona, Barcelona, Spain.; Plataforma Immunoteràpia Hospital Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Menéndez P; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Biomedicine, School of Medicine, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.; Immunotherapy and Cell Engineering Laboratory, Department of Engineering, Aarhus University, Aarhus, Denmark.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Zanetti SR; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain. Electronic address: samzanetti@gmail.com.; Velasco-Hernandez T; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain. Electronic address: tvelasco@carrerasresearch.org.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain.; Díaz VM; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; OneChain Immunotherapeutics S.L., Barcelona, Spain; Faculty of Medicine and Health Sciences, International University of Catalonia, Sant Cugat del Vallès 08195, Spain.; Romecín PA; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain.; Roca-Ho H; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain.; Sánchez-Martínez D; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain.; Tirado N; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain.; Baroni ML; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain.; Petazzi P; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain.; Torres-Ruiz R; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain; Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Molina O; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain.; Bataller A; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; Department of Hematology, Hospital Clínic de Barcelona, Barcelona 08036, Spain.; Fuster JL; RICORS-TERAV, ISCIII, Madrid, Spain; Sección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia 30120, Spain.; Ballerini P; Department of Pediatric Hemato-oncology, Hospital Armand Trousseau, Paris 75012, France.; Juan M; RICORS-TERAV, ISCIII, Madrid, Spain; Department of Immunology, Hospital Clínic de Barcelona and Hospital Sant Joan de Déu, Barcelona 08950, Spain.; Jeremias I; Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich, German Center for Environmental Health (HMGU), Munich 85764, Germany; Department of Pediatrics, Dr von Hauner Children's Hospital, LMU, Munich 80337, Germany.; Bueno C; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain; CIBER-ONC, ISCIII, Barcelona, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Carrer Casanova 143, 4° floor, Barcelona 08036, Spain; RICORS-TERAV, ISCIII, Madrid, Spain; CIBER-ONC, ISCIII, Barcelona, Spain; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona 08036, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: pmenendez@carrerasresearch.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Díaz de la Guardia R; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Velasco-Hernandez T; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Gutiérrez-Agüera F; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Roca-Ho H; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Molina O; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Nombela-Arrieta C; Department of Medical Oncology and Hematology, University and University Hospital Zurich, Zurich, Switzerland.; Bataller A; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Sevicio de Hematología Clínica, Hospital Clínic de Barcelona, Barcelona, Spain.; Fuster JL; Sección de Oncohematología Pediátrica, Hospital Clínico Universitario Virgen de Arrixaca, Instituto Murciano de Investigación Biosanitaria, Murcia, Spain.; Anguita E; Servicio de Hematología, Hospital Clínico San Carlos, IdISSC, Medicina UCM, Madrid, Spain.; Vives S; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Hematology Department, ICO-Hospital Germans Trias i Pujol, Barcelona, Spain.; Zamora L; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Hematology Department, ICO-Hospital Germans Trias i Pujol, Barcelona, Spain.; Nomdedeu J; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Servicio de Hematología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Gómez-Casares MT; Servicio de Hematología, Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain.; Ramírez-Orellana M; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.; Lapillonne H; Haematology Laboratory, AP-HP, Hôpital Armand Trousseau, Centre de Recherche Saint-Antoine CRSA, INSERM, Sorbonne Université, Paris, France.; Ramos-Mejia V; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Rodríguez-Manzaneque JC; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Bueno C; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigacion Biomedica en Red-Oncología (CIBERONC); and.; Lopez-Millan B; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Haematology Laboratory, AP-HP, Hôpital Armand Trousseau, Centre de Recherche Saint-Antoine CRSA, INSERM, Sorbonne Université, Paris, France.; Instituciò Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Gutierrez-Agüera F; Josep Carreras Research Institute, Barcelona, Spain.; Rodriguez-Cortez V; Josep Carreras Research Institute, Barcelona, Spain.; Petazzi P; Josep Carreras Research Institute, Barcelona, Spain.; Bueno C; Josep Carreras Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Menendez P; Josep Carreras Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE

Sánchez-Martínez D; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Baroni ML; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Roca-Ho H; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Blanch-Lombarte O; AIDS Research Institute IrsiCaixa, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.; González-García S; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; Torrebadell M; Haematology Laboratory, Institut de Recerca, Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.; Junca J; Institut Catala d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Ramírez-Orellana M; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.; Velasco-Hernández T; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Bueno C; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Fuster JL; Sección de Oncohematología Pediátrica, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria, Murcia, Spain.; Prado JG; AIDS Research Institute IrsiCaixa, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.; Calvo J; Univerité Paris Diderot and Université Paris-Sud, Unité Mixte de Recherche 967, INSERM, U967, Fontenay-aux-Roses, France.; Uzan B; Univerité Paris Diderot and Université Paris-Sud, Unité Mixte de Recherche 967, INSERM, U967, Fontenay-aux-Roses, France.; Cools J; KU Center for Human Genetics and VIB Center for Cancer Biology, Leuven, Belgium.; Camos M; Haematology Laboratory, Institut de Recerca, Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.; Pflumio F; Univerité Paris Diderot and Université Paris-Sud, Unité Mixte de Recherche 967, INSERM, U967, Fontenay-aux-Roses, France.; Toribio ML; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomedica en Red-Oncología, Instituto de Salud Carlos III, Barcelona, Spain; and.; Instituciò Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Sánchez-Martínez D; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Gutiérrez-Agüera F; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Romecin P; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Vinyoles M; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Palomo M; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Tirado N; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Zanetti SR; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Juan M; Servei d'Immunologia, Hospital Clínic de Barcelona, Barcelona, Spain.; Carlet M; Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich, German Center for Environmental Health (HMGU), Munich, Germany.; Department of Pediatrics, Dr von Hauner Children's Hospital, LMU, Munich, Germany.; Jeremias I; Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich, German Center for Environmental Health (HMGU), Munich, Germany.; Department of Pediatrics, Dr von Hauner Children's Hospital, LMU, Munich, Germany.; Menéndez P; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Print ISSN: 2001-1326 (Print) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med

Molina O; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Vinyoles M; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Granada I; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Hematology Laboratory, Germans Trias i Pujol University Hospital-Catalan Institute of Oncology, Badalona, Spain.; Roca-Ho H; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Valledor L; Department of Physical and Analytical Chemistry, University of Oviedo, Asturias, Spain.; López-López CM; Department of Physical and Analytical Chemistry, University of Oviedo, Asturias, Spain.; Rodríguez-González P; Department of Physical and Analytical Chemistry, University of Oviedo, Asturias, Spain.; Trincado JL; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Menéndez ST; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Oviedo, Spain.; CIBER-ONC, ISCIII, Madrid, Spain.; Pal D; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.; Ballerini P; Pediatric Hematology, A. Trousseau Hospital, Paris, France.; den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Plensa I; Hematology Laboratory, Institut Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Mar Perez-Iribarne M; Hematology Laboratory, Institut Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Rodríguez-Perales S; Molecular Cytogenetics Group, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.; Calasanz MJ; CIMA Laboratory Diagnostics, Universidad de Navarra, Pamplona, Spain.; Ramírez-Orellana M; Hematology Diagnostic Laboratory, Hospital Niño Jesús, Madrid, Spain.; Rodríguez R; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Oviedo, Spain.; CIBER-ONC, ISCIII, Madrid, Spain.; Camós M; Hematology Laboratory, Institut Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Leukemia and Other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain.; Calvo M; Scientific and Technological Centers, Universitat de Barcelona (CCiTUB) Campus Clínic, Barcelona, Spain; and.; Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Petazzi P; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: ppetazzi@carrerasresearch.org.; Torres-Ruiz R; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Fidanza A; MRC Centre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.; Roca-Ho H; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Castaño J; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Rodriguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Díaz de la Guardia R; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; López-Millán B; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Bigas A; Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer-CIBER-ONC, ISCIII, Barcelona, Spain.; Forrester LM; MRC Centre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.; Bueno C; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer-CIBER-ONC, ISCIII, Barcelona, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer-CIBER-ONC, ISCIII, Barcelona, Spain; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: pmenendez@carrerasresearch.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE

Bueno C; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. cbueno@carrerasresearch.org.; Velasco-Hernandez T; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Gutiérrez-Agüera F; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Zanetti SR; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Baroni ML; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Sánchez-Martínez D; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Molina O; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Closa A; Pompeu Fabra University, Barcelona, Spain.; Agraz-Doblás A; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.; Marín P; Hematology Department, Hospital Clínico de Barcelona, Barcelona, Spain.; Eyras E; Pompeu Fabra University, Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Varela I; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. pmenendez@carrerasresearch.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain. pmenendez@carrerasresearch.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Lopez-Millan B; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain. blopez@carrerasresearch.org.; Sanchéz-Martínez D; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Roca-Ho H; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Gutiérrez-Agüera F; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Molina O; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Diaz de la Guardia R; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Torres-Ruiz R; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Fuster JL; Pediatric Hematology and Oncology Section, Hospital Clínico Virgen de la Arrixaca, Murcia, Spain.; Ballerini P; Pediatric Hematology, Armand Trousseau Hospital, Paris, France.; Suessbier U; Hematology Department, University Hospital-University of Zurich, Zurich, Switzerland.; Nombela-Arrieta C; Hematology Department, University Hospital-University of Zurich, Zurich, Switzerland.; Bueno C; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain. cbueno@carrerasresearch.org.; Centro de Investigacion Biomedica en Red-Oncología (CIBERONC), Zurich, Switzerland. cbueno@carrerasresearch.org.; Menéndez P; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.; Centro de Investigacion Biomedica en Red-Oncología (CIBERONC), Zurich, Switzerland. pmenendez@carrerasresearch.org.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. pmenendez@carrerasresearch.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE